SHA:688068

2 stories mentioning SHA:688068Updated 56d ago

Every FINWIRES story that references SHA:688068, newest first.

China Approves Pancreatitis Indication for Beijing Hotgen Biotech's Injection

China's drug regulator accepted the addition of severe acute pancreatitis as an indication for Beijing Hotgen Biotech (SHA:688068) subsidiary Beijing Shunjing Biopharmaceutical Technology's SGC001 injection.The drug is also indicated for acute myocardial infarction, according to a Tuesday filing with the Shanghai bourse.

SHA:688068

Asia56d ago

Hotgen Biotech Plans Up to 100-Million-Yuan Share Buyback

Beijing Hotgen Biotech (SHA:688068) plans to repurchase between 50 million yuan and 100 million yuan of its shares via centralized bidding.The shares will be bought back for up to 166 yuan per share during the three-month buyback period, according to a Tuesday filing with the Shanghai bourse.Shares of the biotechnology company were down 2% in recent trade.

SHA:688068

Track with the FINWIRES app suite

FolioX

Track SHA:688068 in your portfolio

WheelAI

Analyze SHA:688068 options with the wheel strategy

StockInsider

See market sentiment on SHA:688068